Over the past year, new CAR-T cancer therapies have turned into a sizzling new development field in biopharma–and now Johnson & Johnson (NYSE:JNJ) wants in. The pharma giant is following in the footsteps of pioneers like Novartis, Celgene and GlaxoSmithKline, inking a discovery-stage development deal–but turning to the little-known Transposagen Biopharmaceuticals to make its entry. Johnson & Johnson (NYSE:JNJ) belongs to Healthcare sector. Its net profit margin is 29.60% and weekly performance is -1.32%. On last trading day company shares ended up $106.70. Johnson & Johnson (NYSE:JNJ) distance from 50-day simple moving average (SMA50) is 1.91%.

Skyworks Solutions (NASDAQ:SWKS) Director David J. Mclachlan sold 2,000 shares of Skyworks Solutions stock on the open market in a transaction dated Wednesday, November 19th. The stock was sold at an average price of $63.45, for a total value of $126,900.00. Following the transaction, the director now directly owns 47,765 shares of the company’s stock, valued at approximately $3,030,689. Skyworks Solutions Inc. (NASDAQ:SWKS) shares fell -0.40% in last trading session and ended the day at $65.47. SWKS Gross Margin is 44.60% and its return on assets is 17.20%. Skyworks Solutions Inc. (NASDAQ:SWKS) quarterly performance is 19.60%.

The Brink’s Company (NYSE:BCO), will participate at the Imperial Capital Security Investor Conference, which will be held on December 11, 2014, at the Waldorf Astoria hotel in New York City. Joseph W. Dziedzic, vice president and chief financial officer, will be available to meet with investors throughout the day. Portfolio managers and analysts who wish to request a meeting with Brink’s should contact their Imperial Capital representative. On 25 November, The Brink’s Company (NYSE:BCO) shares increased 1.19% and was closed at $22.17. BCO EPS growth in last 5 year was -12.20%. The Brink’s Company (NYSE:BCO) year to date (YTD) performance is -34.31%.

Jefferies Group began coverage on shares of Paycom Software (NYSE:PAYC) in a research note issued to investors on Thursday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $32.00 price target on the stock. Paycom Software, Inc. (NYSE:PAYC) ended the last trading day at $27.68. Company weekly volatility is calculated as 5.14% and price to cash ratio as 76.47. Paycom Software, Inc. (NYSE:PAYC) showed a weekly performance of 11.43%.

Tableau Software, Inc. (NYSE:DATA) issued an update on its growth in the Europe, Middle East, and Africa (EMEA) region. For the third quarter of 2014, the company reported 100 percent revenue growth in EMEA, year-over-year. In addition, the firm has reached more than 5,000 customer accounts in over 90 countries in the EMEA region; and more than 150 employees across EMEA. Tableau Software, Inc. (NYSE:DATA) belongs to Technology sector. Its net profit margin is -1.00% and weekly performance is 0.04%. On last trading day company shares ended up $82.13. Tableau Software, Inc. (NYSE:DATA) distance from 50-day simple moving average (SMA50) is 8.46%.